Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis [Phase 4]
A Phase 4 study (PACE) evaluating physical activity in patients with relapsing-remitting multiple sclerosis treated with fingolimod was term…
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1) [Phase 2]
Phase 2 clinical trial of Plovamer Acetate for relapsing-remitting multiple sclerosis was terminated; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome [Phase 2]
A Phase 2 trial evaluating Trichuris suis ova (TSO) for relapsing-remitting multiple sclerosis and clinically isolated syndrome has been ter…
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS [Phase 4]
Phase 4 evaluation of autonomic nervous system effects during the first dose of 0.5 mg fingolimod (Gilenya) in relapsing-remitting multiple …
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis [Phase 3]
This clinical trial update reports on a Phase 3 study evaluating the safety and efficacy of pravastatin in relapsing-remitting multiple scle…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Extension Study of MT-1303 [Phase 2]
This clinical trial update notes the completion of the Phase 2 extension study of MT-1303 for Relapsing-remitting Multiple Sclerosis, sponso…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: A Cooperative Clinical Study of Abatacept in Multiple Sclerosis [Phase 2]
Phase 2 cooperative trial evaluating abatacept in relapsing-remitting multiple sclerosis has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)
Biogen-sponsored trial (NCT02323269) evaluates dimethyl fumarate for relapsing-remitting multiple sclerosis, focusing on patient-reported ou…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS [Phase 1]
This Phase 1 study evaluates autologous mesenchymal stem cell transplantation in people with relapsing-remitting, secondary progressive, or …
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis [Phase 2]
Open-label extension of Opexa Therapeutics' TERMS Phase 2 trial for relapsing forms of multiple sclerosis was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients [NA]
This trial compares high-dose oral vitamin D3 versus intramuscular vitamin D3 supplementation in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Worms for Immune Regulation of Multiple Sclerosis [Phase 2]
Phase 2 trial evaluating helminth-based immunomodulation for relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis [Phase 2]
Extension Phase 2 study assessing safety and efficacy of Natalizumab in Japanese participants with Relapsing-Remitting Multiple Sclerosis; r…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Safety and Tolerability of Glatiramer Acetate [Phase 3]
Phase 3 trial evaluating the safety and tolerability of glatiramer acetate in Relapsing-Remitting Multiple Sclerosis has completed with resu…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Development of a Motivational Intervention to Improve Treatment Adherence in MS [NA]
A completed clinical trial evaluating a motivational intervention to improve treatment adherence in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating allogeneic human umbilical cord mesenchymal stem cells with Liberation Therapy for relapsing-remitting m…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design
A pilot crossover study evaluating disease stability in Relapsing Remitting Multiple Sclerosis by switching between natalizumab and dimethyl…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment
This clinical trial update reports on an observational study evaluating how nurse support and disease factors influence long-term adherence …
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Vitamin D Pilot Study in Patients With Multiple Sclerosis [Phase 1]
Phase 1 pilot trial evaluating Vitamin D (cholecalciferol) in Relapsing Remitting Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Melatonin in Relapsing-Remitting Multiple Sclerosis Patients [Phase 2]
Phase 2 clinical trial evaluating melatonin in relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Phase I BP Interferon (IFN) Beta-004 [Phase 1]
Phase I trial update shows BP Interferon Beta-004 in relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: Phase I BP Interferon (IFN) Beta-001 [Phase 1]
Phase I trial update for BP Interferon Beta-001 in relapsing-remitting multiple sclerosis, with Phase 1 completed.
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS) [Phase 2]
A Phase 2 exploratory study evaluating multiple regimens of Natalizumab in adults with Relapsing-Remitting Multiple Sclerosis has completed.…
-
CLINICAL_TRIALS trial_result · 2015-07-17Clinical Trial Update: Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)
A completed clinical trial evaluating how Betaferon injection management influences adherence, patient satisfaction, and health-related outc…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change [Phase 4]
Phase 4 clinical trial in relapsing-remitting multiple sclerosis evaluating candidates for changing MS therapy; results were posted in 2015.